Bone Therapeutics SA - ESG Rating & Company Profile powered by AI
If you are employed by Bone Therapeutics SA and you wish to use your ESG rating, please contact us. Alternative companies in the rating peer group for Bone Therapeutics SA are shownin the table. This Sustainability assessment for Bone Therapeutics SA represents the company's reporting of the UN SDGs.
Bone Therapeutics SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 8.0, social score of 8.0 and governance score of 2.7.
6.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 427 | Scancell Holdings PLC | 6.3 | High |
| 427 | Verastem Inc | 6.3 | High |
| 450 | Bone Therapeutics SA | 6.2 | High |
| 450 | Cannasouth Ltd | 6.2 | High |
| 450 | CareDx International AB | 6.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Bone Therapeutics SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Bone Therapeutics SA disclose current and historical energy intensity?
Sign up for free to unlockDoes Bone Therapeutics SA report the average age of the workforce?
Sign up for free to unlockDoes Bone Therapeutics SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Bone Therapeutics SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Bone Therapeutics SA disclose cybersecurity risks?
Sign up for free to unlockDoes Bone Therapeutics SA offer flexible work?
Sign up for free to unlockDoes Bone Therapeutics SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Bone Therapeutics SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Bone Therapeutics SA conduct supply chain audits?
Sign up for free to unlockDoes Bone Therapeutics SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Bone Therapeutics SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Bone Therapeutics SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Bone Therapeutics SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Bone Therapeutics SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Bone Therapeutics SA disclose water use targets?
Sign up for free to unlockDoes Bone Therapeutics SA have careers partnerships with academic institutions?
Sign up for free to unlockDid Bone Therapeutics SA have a product recall in the last two years?
Sign up for free to unlockDoes Bone Therapeutics SA disclose incidents of discrimination?
Sign up for free to unlockDoes Bone Therapeutics SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Bone Therapeutics SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Bone Therapeutics SA disclose parental leave metrics?
Sign up for free to unlockDoes Bone Therapeutics SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Bone Therapeutics SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Bone Therapeutics SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Bone Therapeutics SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Bone Therapeutics SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Bone Therapeutics SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Bone Therapeutics SA involved in embryonic stem cell research?
Sign up for free to unlockDoes Bone Therapeutics SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Bone Therapeutics SA disclose its waste policy?
Sign up for free to unlockDoes Bone Therapeutics SA report according to TCFD requirements?
Sign up for free to unlockDoes Bone Therapeutics SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Bone Therapeutics SA disclose energy use targets?
Sign up for free to unlockDoes Bone Therapeutics SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Bone Therapeutics SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Bone Therapeutics SA
These potential risks are based on the size, segment and geographies of the company.
Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.